ImageneBio Inc. (IMA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for ImageneBio Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$4.20
+3.58% today
Market cap
$46M
Overall quality
—
Kronos AI 30-day
+44.9%
8 of 8 simulated paths end higher
ImageneBio Inc. (IMA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $46M. It trades at $4.20, up 3.58% today. 3 analysts' average target of $15.00 implies +257.1% from today's price. Kronos AI's 30-day forecast is +44.9% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $15.00 |
| Low – high | $2.00 – $28.00 |
| Analysts | 3 |
| Upside to average | +257.1% |
Kronos AI 30-day forecast
| Expected close | $5.83 (+44.9%) |
| Likely range | +32.7% … +52.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.